FDA Draft Guidance Stretches Nanotech “Perhaps Massively” – Trade Group
This article was originally published in The Tan Sheet
Executive Summary
FDA's draft guidance suggesting ingredients up to 1 micrometer in size that exhibit “altered properties” still qualify as nanomaterials should be revised to avoid confusion in the marketplace and promote international harmonization, according to the Personal Care Products Council.
You may also be interested in...
CHPA Urges Nuanced, Risk-Based Approach To Nanotechnology
FDA should not use size alone to regulate nanotechnology, the Consumer Healthcare Products Association says.
FDA Nanotech Guidance Takes Small Step Forward
FDA initiates a dialogue with industry on nanotechnology in regulated products via a broad draft guidance document.
Beauty Packaging Producers: July Marks Registration Deadline With PRO In Three States
Companies considered producers of single-use packaging in Oregon, Colorado and California must register with Circular Action Alliance, the leading (and currently only) producer responsibility organization, by 1 July 2024 under new state recycling laws.